251 related articles for article (PubMed ID: 11156560)
41. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
Puri RN; Kumar A; Chen H; Colman RF; Colman RW
J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
[TBL] [Abstract][Full Text] [Related]
42. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
43. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans.
Asai F; Jakubowski JA; Naganuma H; Brandt JT; Matsushima N; Hirota T; Freestone S; Winters KJ
Platelets; 2006 Jun; 17(4):209-17. PubMed ID: 16769598
[TBL] [Abstract][Full Text] [Related]
44. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
45. Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide.
Kirkby NS; Lundberg MH; Chan MV; Vojnovic I; Solomon AB; Emerson M; Mitchell JA; Warner TD
Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15782-7. PubMed ID: 24003163
[TBL] [Abstract][Full Text] [Related]
46. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
47. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
Xu B; Stephens A; Kirschenheuter G; Greslin AF; Cheng X; Sennelo J; Cattaneo M; Zighetti ML; Chen A; Kim SA; Kim HS; Bischofberger N; Cook G; Jacobson KA
J Med Chem; 2002 Dec; 45(26):5694-709. PubMed ID: 12477353
[TBL] [Abstract][Full Text] [Related]
48. Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor.
Algaier I; Jakubowski JA; Asai F; von Kügelgen I
J Thromb Haemost; 2008 Nov; 6(11):1908-14. PubMed ID: 18752581
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
[TBL] [Abstract][Full Text] [Related]
50. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
51. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
[TBL] [Abstract][Full Text] [Related]
52. Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis.
van Giezen JJ; Berntsson P; Zachrisson H; Björkman JA
Thromb Res; 2009 Nov; 124(5):565-71. PubMed ID: 19692114
[TBL] [Abstract][Full Text] [Related]
53. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
54. The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
Judge HM; Buckland RJ; Sugidachi A; Jakubowski JA; Storey RF
Platelets; 2008 Mar; 19(2):125-33. PubMed ID: 18297550
[TBL] [Abstract][Full Text] [Related]
55. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients.
Polgár J; Eichler P; Greinacher A; Clemetson KJ
Blood; 1998 Jan; 91(2):549-54. PubMed ID: 9427708
[TBL] [Abstract][Full Text] [Related]
56. Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor.
Moore DJ; Chambers JK; Murdock PR; Emson PC
Neuropharmacology; 2002 Nov; 43(6):966-78. PubMed ID: 12423666
[TBL] [Abstract][Full Text] [Related]
57. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
58. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
59. Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.
Sistare FD; Rosenzweig BA; Contrera JG; Jordan B
J Pharmacol Exp Ther; 1994 Jun; 269(3):1049-61. PubMed ID: 8014849
[TBL] [Abstract][Full Text] [Related]
60. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
Sanderson HM; Heptinstall S; Vickers J; Lösche W
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]